Last edition
News about "chronic obstructive pulmonary disease"
EMA Approves Dupixent as First-Ever Targeted Therapy for Patients with COPD
The European Medicines Agency (EMA) has recently announced their approval for Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.
Chronic Obstructive Pulmonary Disease | 04/07/2024 | By Aishwarya | 104
Verona Pharma Secures US FDA Approval of Ohtuvayre
Verona Pharma has announced that the US Food and Drug Administration (FDA) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
Chronic Obstructive Pulmonary Disease | 27/06/2024 | By Aishwarya | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy